Hepatic arterial infusion chemotherapy plus sintilimab as conversion therapy for locally advanced hepatocellular carcinoma: a single-center phase II trial
Hepatic arterial infusion chemotherapy plus sintilimab exhibited impressive outcomes and safety as a conversion therapy for locally aHCC.
Authors
- Chuan Peng (ORCID: https://orcid.org/0000-0002-4513-2491)
- Y. Pan
- M. C. Chen
- S Lu
- Liwen Xu (ORCID: https://orcid.org/0000-0003-2133-8257)
- Ting Wang (ORCID: https://orcid.org/0000-0003-0667-6709)
- Zhongguo Zhou (ORCID: https://orcid.org/0000-0002-6520-195X)
- Yizhen Fu
- Chao Zhang
- Yaojun Zhang
- Xiaohui Wang
- Jing Zhao
Institutions
- Sun Yat-sen University (CN)
- Hunan Normal University (CN)
- Sun Yat-sen University Cancer Center (CN)
- Hunan Provincial People's Hospital (CN)
- State Key Laboratory of Oncology in South China
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1097/js9.0000000000004692
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00